Alexei Gogolev
Stock Analyst at JP Morgan
(3.79)
# 589
Out of 5,182 analysts
101
Total ratings
56%
Success rate
6.81%
Average return
Main Sectors:
Stocks Rated by Alexei Gogolev
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHR Phreesia | Downgrades: Neutral | $24 → $16 | $8.37 | +91.16% | 3 | Mar 31, 2026 | |
| WIX Wix.com | Downgrades: Underweight | $114 → $91 | $81.95 | +11.04% | 6 | Mar 27, 2026 | |
| BRZE Braze | Maintains: Overweight | $32 → $33 | $23.68 | +39.36% | 2 | Mar 25, 2026 | |
| HQY HealthEquity | Maintains: Overweight | $129 → $123 | $84.63 | +45.34% | 2 | Mar 18, 2026 | |
| VEEV Veeva Systems | Maintains: Overweight | $330 → $296 | $173.98 | +70.13% | 2 | Feb 20, 2026 | |
| DOCS Doximity | Maintains: Neutral | $40 → $33 | $22.77 | +44.93% | 3 | Feb 20, 2026 | |
| INTA Intapp | Maintains: Overweight | $70 → $58 | $24.78 | +134.06% | 4 | Feb 4, 2026 | |
| PTC PTC Inc. | Downgrades: Underweight | $205 → $162 | $142.65 | +13.56% | 2 | Feb 2, 2026 | |
| APPF AppFolio | Maintains: Overweight | $330 → $300 | $157.11 | +90.95% | 5 | Jan 30, 2026 | |
| VRSN VeriSign | Maintains: Neutral | $270 → $271 | $259.85 | +4.29% | 2 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $46 → $48 | $32.26 | +48.79% | 5 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $65 → $74 | $42.62 | +73.63% | 1 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $26 | $23.80 | +9.24% | 6 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $56 → $51 | $34.60 | +47.40% | 3 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $200 | $81.67 | +144.89% | 7 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $86 → $94 | $68.33 | +37.57% | 3 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 → $101 | $39.95 | +152.82% | 6 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $271 → $288 | $150.79 | +90.99% | 9 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 → $85 | $58.02 | +46.50% | 8 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $42 → $45 | $16.56 | +171.74% | 4 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $10 → $11 | $11.71 | -6.06% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $526 | $338.03 | +55.61% | 3 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $36 → $32 | $4.12 | +676.70% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $28 | $7.90 | +254.43% | 2 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $247 → $249 | $137.99 | +80.45% | 4 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $73 → $55 | $47.72 | +15.26% | 4 | Mar 11, 2020 |
Phreesia
Mar 31, 2026
Downgrades: Neutral
Price Target: $24 → $16
Current: $8.37
Upside: +91.16%
Wix.com
Mar 27, 2026
Downgrades: Underweight
Price Target: $114 → $91
Current: $81.95
Upside: +11.04%
Braze
Mar 25, 2026
Maintains: Overweight
Price Target: $32 → $33
Current: $23.68
Upside: +39.36%
HealthEquity
Mar 18, 2026
Maintains: Overweight
Price Target: $129 → $123
Current: $84.63
Upside: +45.34%
Veeva Systems
Feb 20, 2026
Maintains: Overweight
Price Target: $330 → $296
Current: $173.98
Upside: +70.13%
Doximity
Feb 20, 2026
Maintains: Neutral
Price Target: $40 → $33
Current: $22.77
Upside: +44.93%
Intapp
Feb 4, 2026
Maintains: Overweight
Price Target: $70 → $58
Current: $24.78
Upside: +134.06%
PTC Inc.
Feb 2, 2026
Downgrades: Underweight
Price Target: $205 → $162
Current: $142.65
Upside: +13.56%
AppFolio
Jan 30, 2026
Maintains: Overweight
Price Target: $330 → $300
Current: $157.11
Upside: +90.95%
VeriSign
Jan 6, 2026
Maintains: Neutral
Price Target: $270 → $271
Current: $259.85
Upside: +4.29%
Dec 5, 2025
Maintains: Neutral
Price Target: $46 → $48
Current: $32.26
Upside: +48.79%
Dec 5, 2025
Maintains: Overweight
Price Target: $65 → $74
Current: $42.62
Upside: +73.63%
Nov 6, 2025
Maintains: Overweight
Price Target: $28 → $26
Current: $23.80
Upside: +9.24%
Nov 6, 2025
Maintains: Neutral
Price Target: $56 → $51
Current: $34.60
Upside: +47.40%
Oct 31, 2025
Maintains: Overweight
Price Target: $222 → $200
Current: $81.67
Upside: +144.89%
Jul 24, 2025
Maintains: Neutral
Price Target: $86 → $94
Current: $68.33
Upside: +37.57%
Jul 23, 2025
Maintains: Overweight
Price Target: $87 → $101
Current: $39.95
Upside: +152.82%
Jun 25, 2025
Maintains: Overweight
Price Target: $271 → $288
Current: $150.79
Upside: +90.99%
Apr 9, 2025
Maintains: Overweight
Price Target: $97 → $85
Current: $58.02
Upside: +46.50%
Dec 9, 2024
Maintains: Overweight
Price Target: $42 → $45
Current: $16.56
Upside: +171.74%
Aug 7, 2024
Maintains: Underweight
Price Target: $10 → $11
Current: $11.71
Upside: -6.06%
Feb 15, 2024
Maintains: Overweight
Price Target: $500 → $526
Current: $338.03
Upside: +55.61%
Aug 9, 2023
Maintains: Underweight
Price Target: $36 → $32
Current: $4.12
Upside: +676.70%
Jul 31, 2023
Maintains: Outperform
Price Target: $27 → $28
Current: $7.90
Upside: +254.43%
Mar 11, 2020
Maintains: Overweight
Price Target: $247 → $249
Current: $137.99
Upside: +80.45%
Mar 11, 2020
Upgrades: Neutral
Price Target: $73 → $55
Current: $47.72
Upside: +15.26%